These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19681859)

  • 21. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial.
    Korgavkar K; Lee KC; Weinstock MA;
    JAMA Dermatol; 2017 Nov; 153(11):1142-1146. PubMed ID: 28877312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
    Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
    Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
    Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
    J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.
    Dyer RK; Weinstock MA; Cohen TS; Rizzo AE; Bingham SF;
    J Invest Dermatol; 2012 Nov; 132(11):2544-51. PubMed ID: 22810303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
    Bertolani MB; Rodighiero E; Gandolfi M; Lotti T; Pedrazzi G; Puviani M; Milani M; Feliciani C; Satolli F
    Dermatol Ther; 2021 Jan; 34(1):e14724. PubMed ID: 33377285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Nunes AP; Lapane KL; Weinstock MA;
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):922-9. PubMed ID: 21688346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical tretinoin in the treatment of aging skin.
    Weiss JS; Ellis CN; Headington JT; Voorhees JJ
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):169-75. PubMed ID: 3045163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies.
    Olsen EA; Katz HI; Levine N; Nigra TP; Pochi PE; Savin RC; Shupack J; Weinstein GD; Lufrano L; Perry BH
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):217-26. PubMed ID: 9270507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream.
    Draelos Z; Tanghetti E; Guenin E
    J Drugs Dermatol; 2022 Aug; 21(8):875-880. PubMed ID: 35946981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.
    Eichenfield LF; Sugarman JL; Guenin E; Harris S; Bhatt V
    Pediatr Dermatol; 2019 Mar; 36(2):193-199. PubMed ID: 30656753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.
    Harper JC; Roberts WE; Zeichner JA; Guenin E; Bhatt V; Pillai R
    J Dermatolog Treat; 2020 Mar; 31(2):160-167. PubMed ID: 30935257
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical tretinoin, another failure in the pursuit of practical chemoprevention for non-melanoma skin cancer.
    Wu PA; Stern RS
    J Invest Dermatol; 2012 Jun; 132(6):1532-5. PubMed ID: 22584499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a history of eczema predict a future basal cell carcinoma?
    Gamba CA; Tang JY
    J Invest Dermatol; 2012 Nov; 132(11):2497-9. PubMed ID: 23069907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
    Kang S; Leyden JJ; Lowe NJ; Ortonne JP; Phillips TJ; Weinstein GD; Bhawan J; Lew-Kaya DA; Matsumoto RM; Sefton J; Walker PS; Gibson JR
    Arch Dermatol; 2001 Dec; 137(12):1597-604. PubMed ID: 11735710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.
    Kang S; Bergfeld W; Gottlieb AB; Hickman J; Humeniuk J; Kempers S; Lebwohl M; Lowe N; McMichael A; Milbauer J; Phillips T; Powers J; Rodriguez D; Savin R; Shavin J; Sherer D; Silvis N; Weinstein R; Weiss J; Hammerberg C; Fisher GJ; Nighland M; Grossman R; Nyirady J
    Am J Clin Dermatol; 2005; 6(4):245-53. PubMed ID: 16060712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial.
    Sumita JM; Miot HA; Soares JLM; Raminelli ACP; Pereira SM; Ogawa MM; Picosse FR; Guadanhim LRS; Enokihara MMSS; Leonardi GR; Bagatin E
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1819-1826. PubMed ID: 29704456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging.
    McDaniel DH; Mazur C; Wortzman MS; Nelson DB
    J Cosmet Dermatol; 2017 Dec; 16(4):542-548. PubMed ID: 28762645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.